Thermo Fisher’s Q1 2025 earnings report revealed a performance as precise as a lab instrument. The company beat expectations ...

With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...

Morgan Stanley lowered the firm’s price target on Thermo Fisher (TMO) to $550 from $678 and keeps an Overweight rating on the shares. While ...

The science-services and instruments provider is expanding operations in the U.S. as companies rearrange manufacturing to avoid new global tariffs. The pharmaceutical industry has long been exempt ...

Raymond James lowered the firm’s price target on Thermo Fisher (TMO) to $525 from $667 and keeps an Outperform rating on the shares. Thermo ...

Thermo Fisher's updated 2025 guidance shows a $1 EPS, or 4.2% hit from tariffs and government spending cuts. Read why I ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four ...

The human identification market is projected to grow from USD 1.2 billion in 2023 to USD 3 billion by 2033, at a CAGR of 9.6% ...

Discover how the hybrid analysis approach drives innovation in materials. Read on for insights into EM and microCT.